Abstract
Cardiovascular disease (CVD) accounts for almost 75% of mortality in subjects with type 2 diabetes (T2DM). The relationship between hypertension, dyslipidaemia and CVD is now well established. However, the precise link between glycaemia and macrovascular complications has remained unclear. There is now emerging evidence that postprandial glucose (PPG) contributes significantly to CVD risk, although to date there are no large scale interventional studies underway which test the hypothesis that targeting PPG will reduce CVD risk. Until recently, there was no consensus about the definition of postprandial hyperglycaemia. The International Diabetes Federation (IDF) has now developed new clinical guidelines for postprandial glucose and recommend that 2-hour post meal glucose levels are kept <7.8 mmol/L. In the last few years more has become known about the cellular mechanisms triggered in response to glucose excursions which may explain this increased susceptibility to CVD. Recently, investigation into the contribution of PPG to HbA(1c) in subjects with T2DM, has shown that this is maximal in relatively well controlled diabetic subjects. Hence PPG is emerging as a legitimate therapeutic target to minimise CVD risk. This review addre...Continue Reading
Citations
Feb 26, 2013·Clinical Drug Investigation·Weiwei ZhangUNKNOWN Gluco VIP study
Jul 2, 2010·Diabetes, Obesity & Metabolism·Y IwamotoH Tachibana
Jun 1, 2010·Journal of Diabetes Investigation·Takashi KadowakiKohei Kaku
Oct 14, 2011·BMC Cardiovascular Disorders·Ruth MartíRafel Ramos
Jun 19, 2013·Indian Journal of Endocrinology and Metabolism·Tarunika BawaAmbrish Mithal
Apr 11, 2014·Diabetes Technology & Therapeutics·Leszek CzupryniakNadia Zherdova
Feb 24, 2011·Current Medical Research and Opinion·Andreas LieblAlexander Simpson
Oct 2, 2012·Diabetes & Metabolism·J VoraS A Ross
Nov 21, 2009·Diabetes Research and Clinical Practice·Hubert KolbRüdiger Landgraf
Oct 24, 2009·Metabolism: Clinical and Experimental·Hideaki NakatsujiIichiro Shimomura
Mar 19, 2014·Diabetes/metabolism Research and Reviews·Chang Yu PanElisabeth Niemoeller
Nov 28, 2012·Primary Care Diabetes·Vito BorzìUNKNOWN IMPROVE™ Study Expert Panel
Jan 10, 2018·Diabetes, Obesity & Metabolism·Jacob IlanyOhad Cohen
Aug 16, 2018·PloS One·Chia-Po FuI-Te Lee
Jul 1, 2012·Expert Review of Endocrinology & Metabolism·Markolf Hanefeld
May 19, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Sarita BajajLeszek Czupryniak
Aug 7, 2010·Southern Medical Journal·Grant C Fowler, Deepa A Vasudevan
Sep 19, 2018·Nutrients·Andrea DalbeniCristiano Fava
Dec 17, 2009·Expert Opinion on Pharmacotherapy·R PeterL M Evans
May 10, 2017·Diabetic Medicine : a Journal of the British Diabetic Association·S K Paul, R R Holman
Jul 7, 2018·Therapeutic Advances in Endocrinology and Metabolism·Lalantha LeelarathnaWitesh Parekh